SCHEMBL29331889

SCHEMBL29331889

C#Cc1c(-c2ccccc2O)cc(-c2ccc(F)cc2)[nH]c1=N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ MAPK14 Q16539 3/20 0.37
▸ GCGR P47871 2/20 0.37
▸ PIM1 P11309 3/20 0.37
▸ ALOX5 P09917 1/20 0.36
▸ BIRC5 O15392 1/20 0.36
▸ GSK3B P49841 1/20 0.35
▸ ERCC1 P07992 1/20 0.35
▸ ERCC4 Q92889 1/20 0.35
▸ CTSV O60911 1/20 0.35
▸ CTSL P07711 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ ALOX12 P18054 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23920029 0.88 PIM1 (0.47) MEN1NPC1KMT2AMAPK14GCGR
SCHEMBL29331866 0.84 MAPK14 (0.49) MEN1KMT2AMAPK14GCGRCTSV
SCHEMBL29332195 0.84 IL4 (0.43) KMT2AMAPK14GCGRGSK3BERCC1
SCHEMBL29332770 0.81 MEN1 (0.46) MEN1NPC1KMT2AMAPK14GCGR
SCHEMBL29331867 0.74 MAPT (0.46) MEN1KMT2AMAPK14GCGRGSK3B
SCHEMBL29331869 0.73 MAPK14 (0.38) MAPK14GCGRPIM1GSK3BKDR
SCHEMBL29332196 0.73 TNKS (0.43) MEN1NPC1KMT2AMAPK14GCGR
SCHEMBL23841138 0.71 ATM (0.57) MEN1KMT2AMAPK14GCGRPIM1
SCHEMBL31695313 0.71 IL4 (0.54) MEN1KMT2AMAPK14GCGRPIM1
SCHEMBL29335418 0.71 IL4 (0.54) MEN1KMT2AMAPK14GCGRPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043621-B2 Small molecule inhibitors of Interleukin-4 TRUSTEES OF BOSTON UNIVERSITY (US) 2024-07-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12043621-B2 Small molecule inhibitors of Interleukin-4 IL4, IL2, IL4I1 MEN1 3952/4885NPC1 4117/4885KMT2A 2798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback